TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. By Cancer History Project May 6, 2005
TCL Archive Cancer research poised for a “platinum age” as a “golden age” ends, NCI director tells AACR annual meeting. By Cancer History Project April 29, 2005
TCL Archive NCI Closes Iressa Trial For NSCLC When Data Indicate No Survival Benefit By Cancer History Project April 29, 2005
TCL Archive U.S., Canada Begin ExCel Trial To Evaluate Aromasin For Breast Cancer Prevention By Cancer History Project April 29, 2005
TCL Archive Also FDA clarifies data requirements for phase I IND applications. By Cancer History Project April 29, 2005
TCL Archive Preoperative Drug Combo Benefits HER-2 Breast Cancer By Cancer History Project April 29, 2005
TCL Archive Combination Radiation/Vaccine May Benefit Some Patients By Cancer History Project April 29, 2005
Article “Backwater to Blockbuster” co-authors Chuck Sherr and Bill Evans on collaborating to write the untold story of the explosive growth of St. Jude Children’s Research Hospital By Cancer History Project
Article Bernie Lewinsky on radiation oncology giants, fifty years of progress, and the healing power of art By Cancer History Project
